Drug Discovery Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Departments of Oncologic Sciences and Chemistry, University of South Florida, Tampa, FL, USA.
Methods Mol Biol. 2023;2705:269-290. doi: 10.1007/978-1-0716-3393-9_15.
This protocol discloses the synthesis of monocarboxylic inhibitors with a macrocyclic peptide scaffold to bind with the GRB2 SH2 domain and disrupt the protein-protein interactions (PPIs) between GRB2 and phosphotyrosine-containing proteins.
本方案揭示了具有大环肽支架的单羧酸抑制剂的合成,以与 GRB2 SH2 结构域结合并破坏 GRB2 和含磷酸酪氨酸蛋白之间的蛋白质-蛋白质相互作用(PPIs)。